Marc Beer has More than Enough Experience to Make Renovia a Success

Marc Beer is the marvelous mind behind the innovative medtech startup Renovia Inc. He also serves as the startup Chief Executive Officer (CEO). Prior to founding Renovia in 2016 Marc was mostly known as the founder of Aegerion Pharmaceuticals. Renovia is a company committed to researching and providing cutting edge therapeutic and diagnostic devices for women with pelvic floor disorders. Marc oversaw the startup’s Series B round of funding which totaled $42 million when you account for venture debt. this allows the startup to progress and release multiple new products for pelvic floor disorders.


Renovia’s base of operations is anchored in Boston, Massachusetts. It was founded with the goal of providing innovative solutions for pelvic floor health. It is really focusing on improving urinary incontinence in women. The average person doesn’t realize just how many women are affected with this disorder worldwide. Researchers suspect as many as a quarter of a million may be affected. The first Renovia product that was approved by the FDA was Leva earlier this year.


Arguably the most avid supporter of Renovia is the Longwood Fund. Longwood is a healthcare-focused investing firm that believed in Renovia early on and also contributed during the Series B round. Renovia plans on using the funds to thoroughly research additional therapeutic and diagnostic products.


Marc Beer has given many thanks to the healthcare investors who donated funds towards their oveall vision at Renovia. His goal is to help improve the lives of women suffering from pelvic floor disorders through the medtech company.


Marc moved into his next venture, Renovia, just a year after departing from Aegerion. He left the company amidst some controversy around Juxtapid, a drug that is used in the treatment of a rare form of high cholesterol.


Marc Beer has more than 2 decades of experience in both the biotech and pharmaceutical fields. Viacell was the first biotech company Marc founded nearly 20 years ago. With him at the helm the company went public just 5 years after its founding and was acquired by PerkinElmer 2 years after that. He also served as the company’s CEO. Learn more:

Leave a Reply

Your email address will not be published. Required fields are marked *